Frontiers in Cardiovascular Medicine-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2260117, encodeId=f74e226011e42, content=审稿速度:6.0 偏重的研究方向：临床 经验分享：请问这个期刊审稿周期如何啊？我的在Editorial Assignment 3个月了。Your manuscript has been submitted and is now in the editorial assignment stage. We are in the process of appointing an editor and reviewers.一直是这个状态，联系期刊和编辑1周了都没人回复。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b0ef1674859, createdName=冰冷仙境, createdTime=Sat Apr 12 10:05:31 CST 2025, time=2025-04-12, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2183059, encodeId=55d421830598e, content=23年7月投的，24年1月接收。等的时间有点长，着急毕业不推荐。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=176c8575575, createdName=ms2000000620153331, createdTime=Sun Jan 21 21:36:51 CST 2024, time=2024-01-21, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2203905, encodeId=1d792203905ce, content=被public health建议改投这个子刊，一个月了还在分配编辑，接受的可能性大吗？着急毕业, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=15252542295, createdName=12524002m39暂无昵称, createdTime=Fri May 10 15:08:04 CST 2024, time=2024-05-10, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1226773, encodeId=6df91226e733f, content=今年会不会上预警呢？疯狂扩刊中，国人发表占比近一半！！看了好多帖子，有预测今年可能会被预警，刚中一篇，惊吓！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1391, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=86c21871987, createdName=ms3720148795955021, createdTime=Thu Jun 16 11:52:24 CST 2022, time=2022-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2211676, encodeId=43d622116e67a, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：心血管 经验分享：投了一篇Case，1月21号投的，4月份接收，5月份wos可查, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f9cb8816098, createdName=ms5000001250467069, createdTime=Wed Jun 26 08:50:15 CST 2024, time=2024-06-26, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=1234081, encodeId=e7a2123408112, content=见了鬼了这个杂志审稿人同意接受了但是编辑部竟然给拒绝了这究竟是什么套路, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=956, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dd472576188, createdName=1259390fm84暂无昵称, createdTime=Fri Jul 22 21:44:41 CST 2022, time=2022-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2154102, encodeId=a07a2154102aa, content=大家都推荐审稿人了么，是不是没推就会慢很多, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=221, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21c65468152, createdName=ms6000001243617632, createdTime=Tue Aug 22 21:49:41 CST 2023, time=2023-08-22, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2156078, encodeId=448f21560e8d2, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：心血管;冠心病 经验分享：07.09submitted 07.28interactive review forum activated(major revision) 08.07review of reviewer1 finalized 08.10review of reviewer2 finalized, accepted 09.04published, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=206, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70808239379, createdName=ms2000000203298966, createdTime=Mon Sep 04 20:22:01 CST 2023, time=2023-09-04, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1055535, encodeId=85f81055535e6, content=审稿速度:6.0 | 投稿命中率:50.0 | 版面费用:2490.0 经验分享：分享下自己综述的投稿旅程： 12 Jun 2021：submitted manuscript. 02 Jul 2021：Editorial Office Frontiers in Cardiovascular Medicine assigned new Associate Editor. 02 Sep 2021：Interactive review forum activated. 16 Sep 2021：Submitting Author re-submitted manuscript. 20 Sep 2021：Review of Review Editor 1 finalized. 21 Sep 2021：Review of Review Editor 2 finalized. 27 Sep 2021：Article accepted for publication. 总共历时4个半月，收到录用消息实在太开心啦，2021年JCR分区：Q1，IF，6.05，杂志效率还算不错, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=319, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6c575239091, createdName=隐形的翅膀, createdTime=Tue Sep 28 00:36:24 CST 2021, time=2021-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220843, encodeId=b03212208433f, content=之前一个大修，两个reject，一个endorsed，修回后现在两个finalized，两个reject，还有希望接收吗。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=460, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2d265535018, createdName=ms4000000327895144, createdTime=Thu May 19 09:12:51 CST 2022, time=2022-05-19, status=1, ipAttribution=)]

2025-04-12 冰冷仙境来自河北省

审稿速度:6.0
偏重的研究方向：临床
经验分享：请问这个期刊审稿周期如何啊？我的在Editorial Assignment 3个月了。Your manuscript has been submitted and is now in the editorial assignment stage. We are in the process of appointing an editor and reviewers.一直是这个状态，联系期刊和编辑1周了都没人回复。

10 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2260117, encodeId=f74e226011e42, content=审稿速度:6.0 偏重的研究方向：临床 经验分享：请问这个期刊审稿周期如何啊？我的在Editorial Assignment 3个月了。Your manuscript has been submitted and is now in the editorial assignment stage. We are in the process of appointing an editor and reviewers.一直是这个状态，联系期刊和编辑1周了都没人回复。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b0ef1674859, createdName=冰冷仙境, createdTime=Sat Apr 12 10:05:31 CST 2025, time=2025-04-12, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2183059, encodeId=55d421830598e, content=23年7月投的，24年1月接收。等的时间有点长，着急毕业不推荐。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=176c8575575, createdName=ms2000000620153331, createdTime=Sun Jan 21 21:36:51 CST 2024, time=2024-01-21, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2203905, encodeId=1d792203905ce, content=被public health建议改投这个子刊，一个月了还在分配编辑，接受的可能性大吗？着急毕业, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=15252542295, createdName=12524002m39暂无昵称, createdTime=Fri May 10 15:08:04 CST 2024, time=2024-05-10, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1226773, encodeId=6df91226e733f, content=今年会不会上预警呢？疯狂扩刊中，国人发表占比近一半！！看了好多帖子，有预测今年可能会被预警，刚中一篇，惊吓！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1391, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=86c21871987, createdName=ms3720148795955021, createdTime=Thu Jun 16 11:52:24 CST 2022, time=2022-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2211676, encodeId=43d622116e67a, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：心血管 经验分享：投了一篇Case，1月21号投的，4月份接收，5月份wos可查, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f9cb8816098, createdName=ms5000001250467069, createdTime=Wed Jun 26 08:50:15 CST 2024, time=2024-06-26, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=1234081, encodeId=e7a2123408112, content=见了鬼了这个杂志审稿人同意接受了但是编辑部竟然给拒绝了这究竟是什么套路, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=956, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dd472576188, createdName=1259390fm84暂无昵称, createdTime=Fri Jul 22 21:44:41 CST 2022, time=2022-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2154102, encodeId=a07a2154102aa, content=大家都推荐审稿人了么，是不是没推就会慢很多, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=221, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21c65468152, createdName=ms6000001243617632, createdTime=Tue Aug 22 21:49:41 CST 2023, time=2023-08-22, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2156078, encodeId=448f21560e8d2, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：心血管;冠心病 经验分享：07.09submitted 07.28interactive review forum activated(major revision) 08.07review of reviewer1 finalized 08.10review of reviewer2 finalized, accepted 09.04published, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=206, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70808239379, createdName=ms2000000203298966, createdTime=Mon Sep 04 20:22:01 CST 2023, time=2023-09-04, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1055535, encodeId=85f81055535e6, content=审稿速度:6.0 | 投稿命中率:50.0 | 版面费用:2490.0 经验分享：分享下自己综述的投稿旅程： 12 Jun 2021：submitted manuscript. 02 Jul 2021：Editorial Office Frontiers in Cardiovascular Medicine assigned new Associate Editor. 02 Sep 2021：Interactive review forum activated. 16 Sep 2021：Submitting Author re-submitted manuscript. 20 Sep 2021：Review of Review Editor 1 finalized. 21 Sep 2021：Review of Review Editor 2 finalized. 27 Sep 2021：Article accepted for publication. 总共历时4个半月，收到录用消息实在太开心啦，2021年JCR分区：Q1，IF，6.05，杂志效率还算不错, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=319, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6c575239091, createdName=隐形的翅膀, createdTime=Tue Sep 28 00:36:24 CST 2021, time=2021-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220843, encodeId=b03212208433f, content=之前一个大修，两个reject，一个endorsed，修回后现在两个finalized，两个reject，还有希望接收吗。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=460, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2d265535018, createdName=ms4000000327895144, createdTime=Thu May 19 09:12:51 CST 2022, time=2022-05-19, status=1, ipAttribution=)]

2024-01-21 ms2000000620153331 来自陕西省

23年7月投的，24年1月接收。等的时间有点长，着急毕业不推荐。

159 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2260117, encodeId=f74e226011e42, content=审稿速度:6.0 偏重的研究方向：临床 经验分享：请问这个期刊审稿周期如何啊？我的在Editorial Assignment 3个月了。Your manuscript has been submitted and is now in the editorial assignment stage. We are in the process of appointing an editor and reviewers.一直是这个状态，联系期刊和编辑1周了都没人回复。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b0ef1674859, createdName=冰冷仙境, createdTime=Sat Apr 12 10:05:31 CST 2025, time=2025-04-12, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2183059, encodeId=55d421830598e, content=23年7月投的，24年1月接收。等的时间有点长，着急毕业不推荐。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=176c8575575, createdName=ms2000000620153331, createdTime=Sun Jan 21 21:36:51 CST 2024, time=2024-01-21, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2203905, encodeId=1d792203905ce, content=被public health建议改投这个子刊，一个月了还在分配编辑，接受的可能性大吗？着急毕业, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=15252542295, createdName=12524002m39暂无昵称, createdTime=Fri May 10 15:08:04 CST 2024, time=2024-05-10, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1226773, encodeId=6df91226e733f, content=今年会不会上预警呢？疯狂扩刊中，国人发表占比近一半！！看了好多帖子，有预测今年可能会被预警，刚中一篇，惊吓！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1391, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=86c21871987, createdName=ms3720148795955021, createdTime=Thu Jun 16 11:52:24 CST 2022, time=2022-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2211676, encodeId=43d622116e67a, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：心血管 经验分享：投了一篇Case，1月21号投的，4月份接收，5月份wos可查, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f9cb8816098, createdName=ms5000001250467069, createdTime=Wed Jun 26 08:50:15 CST 2024, time=2024-06-26, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=1234081, encodeId=e7a2123408112, content=见了鬼了这个杂志审稿人同意接受了但是编辑部竟然给拒绝了这究竟是什么套路, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=956, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dd472576188, createdName=1259390fm84暂无昵称, createdTime=Fri Jul 22 21:44:41 CST 2022, time=2022-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2154102, encodeId=a07a2154102aa, content=大家都推荐审稿人了么，是不是没推就会慢很多, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=221, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21c65468152, createdName=ms6000001243617632, createdTime=Tue Aug 22 21:49:41 CST 2023, time=2023-08-22, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2156078, encodeId=448f21560e8d2, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：心血管;冠心病 经验分享：07.09submitted 07.28interactive review forum activated(major revision) 08.07review of reviewer1 finalized 08.10review of reviewer2 finalized, accepted 09.04published, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=206, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70808239379, createdName=ms2000000203298966, createdTime=Mon Sep 04 20:22:01 CST 2023, time=2023-09-04, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1055535, encodeId=85f81055535e6, content=审稿速度:6.0 | 投稿命中率:50.0 | 版面费用:2490.0 经验分享：分享下自己综述的投稿旅程： 12 Jun 2021：submitted manuscript. 02 Jul 2021：Editorial Office Frontiers in Cardiovascular Medicine assigned new Associate Editor. 02 Sep 2021：Interactive review forum activated. 16 Sep 2021：Submitting Author re-submitted manuscript. 20 Sep 2021：Review of Review Editor 1 finalized. 21 Sep 2021：Review of Review Editor 2 finalized. 27 Sep 2021：Article accepted for publication. 总共历时4个半月，收到录用消息实在太开心啦，2021年JCR分区：Q1，IF，6.05，杂志效率还算不错, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=319, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6c575239091, createdName=隐形的翅膀, createdTime=Tue Sep 28 00:36:24 CST 2021, time=2021-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220843, encodeId=b03212208433f, content=之前一个大修，两个reject，一个endorsed，修回后现在两个finalized，两个reject，还有希望接收吗。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=460, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2d265535018, createdName=ms4000000327895144, createdTime=Thu May 19 09:12:51 CST 2022, time=2022-05-19, status=1, ipAttribution=)]

2024-05-10 12524002m39暂无昵称来自北京

被public health建议改投这个子刊，一个月了还在分配编辑，接受的可能性大吗？着急毕业

143 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2260117, encodeId=f74e226011e42, content=审稿速度:6.0 偏重的研究方向：临床 经验分享：请问这个期刊审稿周期如何啊？我的在Editorial Assignment 3个月了。Your manuscript has been submitted and is now in the editorial assignment stage. We are in the process of appointing an editor and reviewers.一直是这个状态，联系期刊和编辑1周了都没人回复。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b0ef1674859, createdName=冰冷仙境, createdTime=Sat Apr 12 10:05:31 CST 2025, time=2025-04-12, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2183059, encodeId=55d421830598e, content=23年7月投的，24年1月接收。等的时间有点长，着急毕业不推荐。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=176c8575575, createdName=ms2000000620153331, createdTime=Sun Jan 21 21:36:51 CST 2024, time=2024-01-21, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2203905, encodeId=1d792203905ce, content=被public health建议改投这个子刊，一个月了还在分配编辑，接受的可能性大吗？着急毕业, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=15252542295, createdName=12524002m39暂无昵称, createdTime=Fri May 10 15:08:04 CST 2024, time=2024-05-10, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1226773, encodeId=6df91226e733f, content=今年会不会上预警呢？疯狂扩刊中，国人发表占比近一半！！看了好多帖子，有预测今年可能会被预警，刚中一篇，惊吓！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1391, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=86c21871987, createdName=ms3720148795955021, createdTime=Thu Jun 16 11:52:24 CST 2022, time=2022-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2211676, encodeId=43d622116e67a, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：心血管 经验分享：投了一篇Case，1月21号投的，4月份接收，5月份wos可查, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f9cb8816098, createdName=ms5000001250467069, createdTime=Wed Jun 26 08:50:15 CST 2024, time=2024-06-26, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=1234081, encodeId=e7a2123408112, content=见了鬼了这个杂志审稿人同意接受了但是编辑部竟然给拒绝了这究竟是什么套路, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=956, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dd472576188, createdName=1259390fm84暂无昵称, createdTime=Fri Jul 22 21:44:41 CST 2022, time=2022-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2154102, encodeId=a07a2154102aa, content=大家都推荐审稿人了么，是不是没推就会慢很多, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=221, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21c65468152, createdName=ms6000001243617632, createdTime=Tue Aug 22 21:49:41 CST 2023, time=2023-08-22, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2156078, encodeId=448f21560e8d2, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：心血管;冠心病 经验分享：07.09submitted 07.28interactive review forum activated(major revision) 08.07review of reviewer1 finalized 08.10review of reviewer2 finalized, accepted 09.04published, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=206, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70808239379, createdName=ms2000000203298966, createdTime=Mon Sep 04 20:22:01 CST 2023, time=2023-09-04, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1055535, encodeId=85f81055535e6, content=审稿速度:6.0 | 投稿命中率:50.0 | 版面费用:2490.0 经验分享：分享下自己综述的投稿旅程： 12 Jun 2021：submitted manuscript. 02 Jul 2021：Editorial Office Frontiers in Cardiovascular Medicine assigned new Associate Editor. 02 Sep 2021：Interactive review forum activated. 16 Sep 2021：Submitting Author re-submitted manuscript. 20 Sep 2021：Review of Review Editor 1 finalized. 21 Sep 2021：Review of Review Editor 2 finalized. 27 Sep 2021：Article accepted for publication. 总共历时4个半月，收到录用消息实在太开心啦，2021年JCR分区：Q1，IF，6.05，杂志效率还算不错, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=319, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6c575239091, createdName=隐形的翅膀, createdTime=Tue Sep 28 00:36:24 CST 2021, time=2021-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220843, encodeId=b03212208433f, content=之前一个大修，两个reject，一个endorsed，修回后现在两个finalized，两个reject，还有希望接收吗。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=460, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2d265535018, createdName=ms4000000327895144, createdTime=Thu May 19 09:12:51 CST 2022, time=2022-05-19, status=1, ipAttribution=)]

2022-06-16 ms3720148795955021

今年会不会上预警呢？疯狂扩刊中，国人发表占比近一半！！看了好多帖子，有预测今年可能会被预警，刚中一篇，惊吓！！

1391 16

展开16条回复

[GetPortalCommentsPageByObjectIdResponse(id=2260117, encodeId=f74e226011e42, content=审稿速度:6.0 偏重的研究方向：临床 经验分享：请问这个期刊审稿周期如何啊？我的在Editorial Assignment 3个月了。Your manuscript has been submitted and is now in the editorial assignment stage. We are in the process of appointing an editor and reviewers.一直是这个状态，联系期刊和编辑1周了都没人回复。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b0ef1674859, createdName=冰冷仙境, createdTime=Sat Apr 12 10:05:31 CST 2025, time=2025-04-12, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2183059, encodeId=55d421830598e, content=23年7月投的，24年1月接收。等的时间有点长，着急毕业不推荐。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=176c8575575, createdName=ms2000000620153331, createdTime=Sun Jan 21 21:36:51 CST 2024, time=2024-01-21, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2203905, encodeId=1d792203905ce, content=被public health建议改投这个子刊，一个月了还在分配编辑，接受的可能性大吗？着急毕业, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=15252542295, createdName=12524002m39暂无昵称, createdTime=Fri May 10 15:08:04 CST 2024, time=2024-05-10, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1226773, encodeId=6df91226e733f, content=今年会不会上预警呢？疯狂扩刊中，国人发表占比近一半！！看了好多帖子，有预测今年可能会被预警，刚中一篇，惊吓！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1391, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=86c21871987, createdName=ms3720148795955021, createdTime=Thu Jun 16 11:52:24 CST 2022, time=2022-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2211676, encodeId=43d622116e67a, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：心血管 经验分享：投了一篇Case，1月21号投的，4月份接收，5月份wos可查, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f9cb8816098, createdName=ms5000001250467069, createdTime=Wed Jun 26 08:50:15 CST 2024, time=2024-06-26, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=1234081, encodeId=e7a2123408112, content=见了鬼了这个杂志审稿人同意接受了但是编辑部竟然给拒绝了这究竟是什么套路, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=956, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dd472576188, createdName=1259390fm84暂无昵称, createdTime=Fri Jul 22 21:44:41 CST 2022, time=2022-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2154102, encodeId=a07a2154102aa, content=大家都推荐审稿人了么，是不是没推就会慢很多, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=221, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21c65468152, createdName=ms6000001243617632, createdTime=Tue Aug 22 21:49:41 CST 2023, time=2023-08-22, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2156078, encodeId=448f21560e8d2, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：心血管;冠心病 经验分享：07.09submitted 07.28interactive review forum activated(major revision) 08.07review of reviewer1 finalized 08.10review of reviewer2 finalized, accepted 09.04published, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=206, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70808239379, createdName=ms2000000203298966, createdTime=Mon Sep 04 20:22:01 CST 2023, time=2023-09-04, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1055535, encodeId=85f81055535e6, content=审稿速度:6.0 | 投稿命中率:50.0 | 版面费用:2490.0 经验分享：分享下自己综述的投稿旅程： 12 Jun 2021：submitted manuscript. 02 Jul 2021：Editorial Office Frontiers in Cardiovascular Medicine assigned new Associate Editor. 02 Sep 2021：Interactive review forum activated. 16 Sep 2021：Submitting Author re-submitted manuscript. 20 Sep 2021：Review of Review Editor 1 finalized. 21 Sep 2021：Review of Review Editor 2 finalized. 27 Sep 2021：Article accepted for publication. 总共历时4个半月，收到录用消息实在太开心啦，2021年JCR分区：Q1，IF，6.05，杂志效率还算不错, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=319, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6c575239091, createdName=隐形的翅膀, createdTime=Tue Sep 28 00:36:24 CST 2021, time=2021-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220843, encodeId=b03212208433f, content=之前一个大修，两个reject，一个endorsed，修回后现在两个finalized，两个reject，还有希望接收吗。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=460, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2d265535018, createdName=ms4000000327895144, createdTime=Thu May 19 09:12:51 CST 2022, time=2022-05-19, status=1, ipAttribution=)]

2024-06-26 ms5000001250467069 来自江西省

审稿速度:3.0 | 投稿命中率:50.0
偏重的研究方向：心血管
经验分享：投了一篇Case，1月21号投的，4月份接收，5月份wos可查

115 0

[GetPortalCommentsPageByObjectIdResponse(id=2260117, encodeId=f74e226011e42, content=审稿速度:6.0 偏重的研究方向：临床 经验分享：请问这个期刊审稿周期如何啊？我的在Editorial Assignment 3个月了。Your manuscript has been submitted and is now in the editorial assignment stage. We are in the process of appointing an editor and reviewers.一直是这个状态，联系期刊和编辑1周了都没人回复。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b0ef1674859, createdName=冰冷仙境, createdTime=Sat Apr 12 10:05:31 CST 2025, time=2025-04-12, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2183059, encodeId=55d421830598e, content=23年7月投的，24年1月接收。等的时间有点长，着急毕业不推荐。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=176c8575575, createdName=ms2000000620153331, createdTime=Sun Jan 21 21:36:51 CST 2024, time=2024-01-21, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2203905, encodeId=1d792203905ce, content=被public health建议改投这个子刊，一个月了还在分配编辑，接受的可能性大吗？着急毕业, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=15252542295, createdName=12524002m39暂无昵称, createdTime=Fri May 10 15:08:04 CST 2024, time=2024-05-10, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1226773, encodeId=6df91226e733f, content=今年会不会上预警呢？疯狂扩刊中，国人发表占比近一半！！看了好多帖子，有预测今年可能会被预警，刚中一篇，惊吓！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1391, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=86c21871987, createdName=ms3720148795955021, createdTime=Thu Jun 16 11:52:24 CST 2022, time=2022-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2211676, encodeId=43d622116e67a, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：心血管 经验分享：投了一篇Case，1月21号投的，4月份接收，5月份wos可查, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f9cb8816098, createdName=ms5000001250467069, createdTime=Wed Jun 26 08:50:15 CST 2024, time=2024-06-26, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=1234081, encodeId=e7a2123408112, content=见了鬼了这个杂志审稿人同意接受了但是编辑部竟然给拒绝了这究竟是什么套路, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=956, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dd472576188, createdName=1259390fm84暂无昵称, createdTime=Fri Jul 22 21:44:41 CST 2022, time=2022-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2154102, encodeId=a07a2154102aa, content=大家都推荐审稿人了么，是不是没推就会慢很多, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=221, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21c65468152, createdName=ms6000001243617632, createdTime=Tue Aug 22 21:49:41 CST 2023, time=2023-08-22, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2156078, encodeId=448f21560e8d2, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：心血管;冠心病 经验分享：07.09submitted 07.28interactive review forum activated(major revision) 08.07review of reviewer1 finalized 08.10review of reviewer2 finalized, accepted 09.04published, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=206, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70808239379, createdName=ms2000000203298966, createdTime=Mon Sep 04 20:22:01 CST 2023, time=2023-09-04, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1055535, encodeId=85f81055535e6, content=审稿速度:6.0 | 投稿命中率:50.0 | 版面费用:2490.0 经验分享：分享下自己综述的投稿旅程： 12 Jun 2021：submitted manuscript. 02 Jul 2021：Editorial Office Frontiers in Cardiovascular Medicine assigned new Associate Editor. 02 Sep 2021：Interactive review forum activated. 16 Sep 2021：Submitting Author re-submitted manuscript. 20 Sep 2021：Review of Review Editor 1 finalized. 21 Sep 2021：Review of Review Editor 2 finalized. 27 Sep 2021：Article accepted for publication. 总共历时4个半月，收到录用消息实在太开心啦，2021年JCR分区：Q1，IF，6.05，杂志效率还算不错, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=319, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6c575239091, createdName=隐形的翅膀, createdTime=Tue Sep 28 00:36:24 CST 2021, time=2021-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220843, encodeId=b03212208433f, content=之前一个大修，两个reject，一个endorsed，修回后现在两个finalized，两个reject，还有希望接收吗。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=460, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2d265535018, createdName=ms4000000327895144, createdTime=Thu May 19 09:12:51 CST 2022, time=2022-05-19, status=1, ipAttribution=)]

2022-07-22 1259390fm84暂无昵称

见了鬼了这个杂志审稿人同意接受了但是编辑部竟然给拒绝了这究竟是什么套路

956 6

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=2260117, encodeId=f74e226011e42, content=审稿速度:6.0 偏重的研究方向：临床 经验分享：请问这个期刊审稿周期如何啊？我的在Editorial Assignment 3个月了。Your manuscript has been submitted and is now in the editorial assignment stage. We are in the process of appointing an editor and reviewers.一直是这个状态，联系期刊和编辑1周了都没人回复。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b0ef1674859, createdName=冰冷仙境, createdTime=Sat Apr 12 10:05:31 CST 2025, time=2025-04-12, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2183059, encodeId=55d421830598e, content=23年7月投的，24年1月接收。等的时间有点长，着急毕业不推荐。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=176c8575575, createdName=ms2000000620153331, createdTime=Sun Jan 21 21:36:51 CST 2024, time=2024-01-21, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2203905, encodeId=1d792203905ce, content=被public health建议改投这个子刊，一个月了还在分配编辑，接受的可能性大吗？着急毕业, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=15252542295, createdName=12524002m39暂无昵称, createdTime=Fri May 10 15:08:04 CST 2024, time=2024-05-10, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1226773, encodeId=6df91226e733f, content=今年会不会上预警呢？疯狂扩刊中，国人发表占比近一半！！看了好多帖子，有预测今年可能会被预警，刚中一篇，惊吓！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1391, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=86c21871987, createdName=ms3720148795955021, createdTime=Thu Jun 16 11:52:24 CST 2022, time=2022-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2211676, encodeId=43d622116e67a, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：心血管 经验分享：投了一篇Case，1月21号投的，4月份接收，5月份wos可查, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f9cb8816098, createdName=ms5000001250467069, createdTime=Wed Jun 26 08:50:15 CST 2024, time=2024-06-26, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=1234081, encodeId=e7a2123408112, content=见了鬼了这个杂志审稿人同意接受了但是编辑部竟然给拒绝了这究竟是什么套路, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=956, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dd472576188, createdName=1259390fm84暂无昵称, createdTime=Fri Jul 22 21:44:41 CST 2022, time=2022-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2154102, encodeId=a07a2154102aa, content=大家都推荐审稿人了么，是不是没推就会慢很多, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=221, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21c65468152, createdName=ms6000001243617632, createdTime=Tue Aug 22 21:49:41 CST 2023, time=2023-08-22, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2156078, encodeId=448f21560e8d2, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：心血管;冠心病 经验分享：07.09submitted 07.28interactive review forum activated(major revision) 08.07review of reviewer1 finalized 08.10review of reviewer2 finalized, accepted 09.04published, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=206, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70808239379, createdName=ms2000000203298966, createdTime=Mon Sep 04 20:22:01 CST 2023, time=2023-09-04, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1055535, encodeId=85f81055535e6, content=审稿速度:6.0 | 投稿命中率:50.0 | 版面费用:2490.0 经验分享：分享下自己综述的投稿旅程： 12 Jun 2021：submitted manuscript. 02 Jul 2021：Editorial Office Frontiers in Cardiovascular Medicine assigned new Associate Editor. 02 Sep 2021：Interactive review forum activated. 16 Sep 2021：Submitting Author re-submitted manuscript. 20 Sep 2021：Review of Review Editor 1 finalized. 21 Sep 2021：Review of Review Editor 2 finalized. 27 Sep 2021：Article accepted for publication. 总共历时4个半月，收到录用消息实在太开心啦，2021年JCR分区：Q1，IF，6.05，杂志效率还算不错, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=319, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6c575239091, createdName=隐形的翅膀, createdTime=Tue Sep 28 00:36:24 CST 2021, time=2021-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220843, encodeId=b03212208433f, content=之前一个大修，两个reject，一个endorsed，修回后现在两个finalized，两个reject，还有希望接收吗。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=460, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2d265535018, createdName=ms4000000327895144, createdTime=Thu May 19 09:12:51 CST 2022, time=2022-05-19, status=1, ipAttribution=)]

2023-08-22 ms6000001243617632 来自湖北省

大家都推荐审稿人了么，是不是没推就会慢很多

221 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2260117, encodeId=f74e226011e42, content=审稿速度:6.0 偏重的研究方向：临床 经验分享：请问这个期刊审稿周期如何啊？我的在Editorial Assignment 3个月了。Your manuscript has been submitted and is now in the editorial assignment stage. We are in the process of appointing an editor and reviewers.一直是这个状态，联系期刊和编辑1周了都没人回复。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b0ef1674859, createdName=冰冷仙境, createdTime=Sat Apr 12 10:05:31 CST 2025, time=2025-04-12, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2183059, encodeId=55d421830598e, content=23年7月投的，24年1月接收。等的时间有点长，着急毕业不推荐。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=176c8575575, createdName=ms2000000620153331, createdTime=Sun Jan 21 21:36:51 CST 2024, time=2024-01-21, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2203905, encodeId=1d792203905ce, content=被public health建议改投这个子刊，一个月了还在分配编辑，接受的可能性大吗？着急毕业, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=15252542295, createdName=12524002m39暂无昵称, createdTime=Fri May 10 15:08:04 CST 2024, time=2024-05-10, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1226773, encodeId=6df91226e733f, content=今年会不会上预警呢？疯狂扩刊中，国人发表占比近一半！！看了好多帖子，有预测今年可能会被预警，刚中一篇，惊吓！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1391, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=86c21871987, createdName=ms3720148795955021, createdTime=Thu Jun 16 11:52:24 CST 2022, time=2022-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2211676, encodeId=43d622116e67a, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：心血管 经验分享：投了一篇Case，1月21号投的，4月份接收，5月份wos可查, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f9cb8816098, createdName=ms5000001250467069, createdTime=Wed Jun 26 08:50:15 CST 2024, time=2024-06-26, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=1234081, encodeId=e7a2123408112, content=见了鬼了这个杂志审稿人同意接受了但是编辑部竟然给拒绝了这究竟是什么套路, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=956, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dd472576188, createdName=1259390fm84暂无昵称, createdTime=Fri Jul 22 21:44:41 CST 2022, time=2022-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2154102, encodeId=a07a2154102aa, content=大家都推荐审稿人了么，是不是没推就会慢很多, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=221, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21c65468152, createdName=ms6000001243617632, createdTime=Tue Aug 22 21:49:41 CST 2023, time=2023-08-22, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2156078, encodeId=448f21560e8d2, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：心血管;冠心病 经验分享：07.09submitted 07.28interactive review forum activated(major revision) 08.07review of reviewer1 finalized 08.10review of reviewer2 finalized, accepted 09.04published, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=206, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70808239379, createdName=ms2000000203298966, createdTime=Mon Sep 04 20:22:01 CST 2023, time=2023-09-04, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1055535, encodeId=85f81055535e6, content=审稿速度:6.0 | 投稿命中率:50.0 | 版面费用:2490.0 经验分享：分享下自己综述的投稿旅程： 12 Jun 2021：submitted manuscript. 02 Jul 2021：Editorial Office Frontiers in Cardiovascular Medicine assigned new Associate Editor. 02 Sep 2021：Interactive review forum activated. 16 Sep 2021：Submitting Author re-submitted manuscript. 20 Sep 2021：Review of Review Editor 1 finalized. 21 Sep 2021：Review of Review Editor 2 finalized. 27 Sep 2021：Article accepted for publication. 总共历时4个半月，收到录用消息实在太开心啦，2021年JCR分区：Q1，IF，6.05，杂志效率还算不错, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=319, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6c575239091, createdName=隐形的翅膀, createdTime=Tue Sep 28 00:36:24 CST 2021, time=2021-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220843, encodeId=b03212208433f, content=之前一个大修，两个reject，一个endorsed，修回后现在两个finalized，两个reject，还有希望接收吗。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=460, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2d265535018, createdName=ms4000000327895144, createdTime=Thu May 19 09:12:51 CST 2022, time=2022-05-19, status=1, ipAttribution=)]

2023-09-04 ms2000000203298966 来自浙江省

审稿速度:1.0 | 投稿命中率:95.0
偏重的研究方向：心血管;冠心病
经验分享：07.09submitted 07.28interactive review forum activated(major revision) 08.07review of reviewer1 finalized 08.10review of reviewer2 finalized, accepted 09.04published

206 0

[GetPortalCommentsPageByObjectIdResponse(id=2260117, encodeId=f74e226011e42, content=审稿速度:6.0 偏重的研究方向：临床 经验分享：请问这个期刊审稿周期如何啊？我的在Editorial Assignment 3个月了。Your manuscript has been submitted and is now in the editorial assignment stage. We are in the process of appointing an editor and reviewers.一直是这个状态，联系期刊和编辑1周了都没人回复。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b0ef1674859, createdName=冰冷仙境, createdTime=Sat Apr 12 10:05:31 CST 2025, time=2025-04-12, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2183059, encodeId=55d421830598e, content=23年7月投的，24年1月接收。等的时间有点长，着急毕业不推荐。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=176c8575575, createdName=ms2000000620153331, createdTime=Sun Jan 21 21:36:51 CST 2024, time=2024-01-21, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2203905, encodeId=1d792203905ce, content=被public health建议改投这个子刊，一个月了还在分配编辑，接受的可能性大吗？着急毕业, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=15252542295, createdName=12524002m39暂无昵称, createdTime=Fri May 10 15:08:04 CST 2024, time=2024-05-10, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1226773, encodeId=6df91226e733f, content=今年会不会上预警呢？疯狂扩刊中，国人发表占比近一半！！看了好多帖子，有预测今年可能会被预警，刚中一篇，惊吓！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1391, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=86c21871987, createdName=ms3720148795955021, createdTime=Thu Jun 16 11:52:24 CST 2022, time=2022-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2211676, encodeId=43d622116e67a, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：心血管 经验分享：投了一篇Case，1月21号投的，4月份接收，5月份wos可查, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f9cb8816098, createdName=ms5000001250467069, createdTime=Wed Jun 26 08:50:15 CST 2024, time=2024-06-26, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=1234081, encodeId=e7a2123408112, content=见了鬼了这个杂志审稿人同意接受了但是编辑部竟然给拒绝了这究竟是什么套路, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=956, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dd472576188, createdName=1259390fm84暂无昵称, createdTime=Fri Jul 22 21:44:41 CST 2022, time=2022-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2154102, encodeId=a07a2154102aa, content=大家都推荐审稿人了么，是不是没推就会慢很多, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=221, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21c65468152, createdName=ms6000001243617632, createdTime=Tue Aug 22 21:49:41 CST 2023, time=2023-08-22, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2156078, encodeId=448f21560e8d2, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：心血管;冠心病 经验分享：07.09submitted 07.28interactive review forum activated(major revision) 08.07review of reviewer1 finalized 08.10review of reviewer2 finalized, accepted 09.04published, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=206, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70808239379, createdName=ms2000000203298966, createdTime=Mon Sep 04 20:22:01 CST 2023, time=2023-09-04, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1055535, encodeId=85f81055535e6, content=审稿速度:6.0 | 投稿命中率:50.0 | 版面费用:2490.0 经验分享：分享下自己综述的投稿旅程： 12 Jun 2021：submitted manuscript. 02 Jul 2021：Editorial Office Frontiers in Cardiovascular Medicine assigned new Associate Editor. 02 Sep 2021：Interactive review forum activated. 16 Sep 2021：Submitting Author re-submitted manuscript. 20 Sep 2021：Review of Review Editor 1 finalized. 21 Sep 2021：Review of Review Editor 2 finalized. 27 Sep 2021：Article accepted for publication. 总共历时4个半月，收到录用消息实在太开心啦，2021年JCR分区：Q1，IF，6.05，杂志效率还算不错, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=319, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6c575239091, createdName=隐形的翅膀, createdTime=Tue Sep 28 00:36:24 CST 2021, time=2021-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220843, encodeId=b03212208433f, content=之前一个大修，两个reject，一个endorsed，修回后现在两个finalized，两个reject，还有希望接收吗。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=460, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2d265535018, createdName=ms4000000327895144, createdTime=Thu May 19 09:12:51 CST 2022, time=2022-05-19, status=1, ipAttribution=)]

2021-09-28 隐形的翅膀

审稿速度:6.0 | 投稿命中率:50.0 | 版面费用:2490.0
经验分享：分享下自己综述的投稿旅程：
12 Jun 2021：submitted manuscript.
02 Jul 2021：Editorial Office Frontiers in Cardiovascular Medicine assigned new Associate Editor.
02 Sep 2021：Interactive review forum activated.
16 Sep 2021：Submitting Author re-submitted manuscript.
20 Sep 2021：Review of Review Editor 1 finalized.
21 Sep 2021：Review of Review Editor 2 finalized.
27 Sep 2021：Article accepted for publication.
总共历时4个半月，收到录用消息实在太开心啦，2021年JCR分区：Q1，IF，6.05，杂志效率还算不错

319 14

展开14条回复

[GetPortalCommentsPageByObjectIdResponse(id=2260117, encodeId=f74e226011e42, content=审稿速度:6.0 偏重的研究方向：临床 经验分享：请问这个期刊审稿周期如何啊？我的在Editorial Assignment 3个月了。Your manuscript has been submitted and is now in the editorial assignment stage. We are in the process of appointing an editor and reviewers.一直是这个状态，联系期刊和编辑1周了都没人回复。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b0ef1674859, createdName=冰冷仙境, createdTime=Sat Apr 12 10:05:31 CST 2025, time=2025-04-12, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2183059, encodeId=55d421830598e, content=23年7月投的，24年1月接收。等的时间有点长，着急毕业不推荐。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=176c8575575, createdName=ms2000000620153331, createdTime=Sun Jan 21 21:36:51 CST 2024, time=2024-01-21, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2203905, encodeId=1d792203905ce, content=被public health建议改投这个子刊，一个月了还在分配编辑，接受的可能性大吗？着急毕业, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=15252542295, createdName=12524002m39暂无昵称, createdTime=Fri May 10 15:08:04 CST 2024, time=2024-05-10, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1226773, encodeId=6df91226e733f, content=今年会不会上预警呢？疯狂扩刊中，国人发表占比近一半！！看了好多帖子，有预测今年可能会被预警，刚中一篇，惊吓！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1391, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=86c21871987, createdName=ms3720148795955021, createdTime=Thu Jun 16 11:52:24 CST 2022, time=2022-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2211676, encodeId=43d622116e67a, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：心血管 经验分享：投了一篇Case，1月21号投的，4月份接收，5月份wos可查, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f9cb8816098, createdName=ms5000001250467069, createdTime=Wed Jun 26 08:50:15 CST 2024, time=2024-06-26, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=1234081, encodeId=e7a2123408112, content=见了鬼了这个杂志审稿人同意接受了但是编辑部竟然给拒绝了这究竟是什么套路, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=956, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dd472576188, createdName=1259390fm84暂无昵称, createdTime=Fri Jul 22 21:44:41 CST 2022, time=2022-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2154102, encodeId=a07a2154102aa, content=大家都推荐审稿人了么，是不是没推就会慢很多, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=221, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21c65468152, createdName=ms6000001243617632, createdTime=Tue Aug 22 21:49:41 CST 2023, time=2023-08-22, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2156078, encodeId=448f21560e8d2, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：心血管;冠心病 经验分享：07.09submitted 07.28interactive review forum activated(major revision) 08.07review of reviewer1 finalized 08.10review of reviewer2 finalized, accepted 09.04published, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=206, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70808239379, createdName=ms2000000203298966, createdTime=Mon Sep 04 20:22:01 CST 2023, time=2023-09-04, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1055535, encodeId=85f81055535e6, content=审稿速度:6.0 | 投稿命中率:50.0 | 版面费用:2490.0 经验分享：分享下自己综述的投稿旅程： 12 Jun 2021：submitted manuscript. 02 Jul 2021：Editorial Office Frontiers in Cardiovascular Medicine assigned new Associate Editor. 02 Sep 2021：Interactive review forum activated. 16 Sep 2021：Submitting Author re-submitted manuscript. 20 Sep 2021：Review of Review Editor 1 finalized. 21 Sep 2021：Review of Review Editor 2 finalized. 27 Sep 2021：Article accepted for publication. 总共历时4个半月，收到录用消息实在太开心啦，2021年JCR分区：Q1，IF，6.05，杂志效率还算不错, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=319, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6c575239091, createdName=隐形的翅膀, createdTime=Tue Sep 28 00:36:24 CST 2021, time=2021-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220843, encodeId=b03212208433f, content=之前一个大修，两个reject，一个endorsed，修回后现在两个finalized，两个reject，还有希望接收吗。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=460, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2d265535018, createdName=ms4000000327895144, createdTime=Thu May 19 09:12:51 CST 2022, time=2022-05-19, status=1, ipAttribution=)]

2022-05-19 ms4000000327895144

之前一个大修，两个reject，一个endorsed，修回后现在两个finalized，两个reject，还有希望接收吗。。。

460 9

展开9条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务